Impact of VEGF Expression on Response to Anti-Angiogenic Therapy in Hepatocellular Carcinoma: A Meta-Analysis of Clinical Trials
Hepatocellular carcinoma (HCC) remains a major global health challenge, with limited effective systemic therapies. The development of targeted agents inhibiting tumor angiogenesis has emerged as a promising strategy, particularly those…